Sol-Gel Technologies Ltd. Ordinary Shares | SLGL

Sol-Gel Technologies Ltd. Ordinary Shares Profile

  • Sector: Health Technology
  • Industry: Pharmaceuticals: Major
  • Employees: 65

Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.

Sol-Gel Technologies Ltd. Ordinary Shares in the news

Services We Offer

Need a custom stock scraper? Want to do some machine learning? We are here to help! Reach out to us!

Machine Learning

Custom Scraper

Automation

Consulting